kff glp-1 Trump Won't Force Medicaid To Cover GLP-1s for Obesity. A Few States Are Doing It Anyway

Employer FAQs on the Rise of GLP-1 Drugs for Weight Loss and the Workplace Impact | Fisher Phillips

27.34

★★★★☆4.8 (126)

While more large employers cover GLP-1 drugs for weight loss, virtually all employers we spoke to in focus groups highlighted cost challenges. Many said they've considered reducing coverage, or in some cases,

20.67

★★★★★4.9 (98)

KFF Health News | Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded. Meanwhile,

25.23

★★★★★5.0 (157)

About 1 in 8 U.S. adults say they are taking a GLP-1 drug, according to a recent survey by the health research group KFF. https://www.cbs42.com/news/health/this-is-the-biggest-mistake-glp-1-users-make-doctor-says/?utm_medium=social&utm_source

27.10

★★★★★4.7 (84)

Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight

24.91

★★★★★4.9 (203)

Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss

27.07

★★★★★5.0 (176)

KFF Health News | In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects, like

22.52

★★★★★4.8 (132)